BioCentury | Jun 27, 2019
Product Development

Gene therapy’s next frontier lies beyond rare, monogenic diseases

...Whereas other companies’ programs target complement factors at more upstream points in the cascade, Hemera Biosciences Inc.’s...
...Harvard, Cambridge, Mass. Gyroscope Therapeutics Ltd., Stevenage, U.K. Encoded Therapeutics Inc., South San Francisco, Calif. Hemera Biosciences Inc....
...RTH258, esba1008) Eylea, VEGF Trap-Eye, aflibercept ophthalmic solution RGX-314 VY-AADC (VY-AADC01) AbbVie Inc. Adverum Biotechnologies Inc. Axovant Gene Therapies Ltd. Gyroscope Therapeutics Ltd. Hemera Biosciences Inc. Neurocrine...
BioCentury | Feb 22, 2019
Emerging Company Profile

Gyroscope complements dry AMD

...mAb tesidolumab. At least one other company is developing a gene therapy for dry AMD. Hemera Biosciences Inc....
...Companies and Institutions Mentioned Apellis Pharmaceuticals Inc. (NASDAQ:APLS), Crestwood, Ky. Gyroscope Therapeutics Ltd., Stevenage, U.K. Hemera Biosciences Inc....
BioCentury | Oct 21, 2013
Emerging Company Profile

Hemera: Special sauce in AMD

...and Institutions Mentioned Bayer AG (Xetra:BAYN), Leverkusen, Germany Genentech Inc. , South San Francisco, Calif. Hemera Biosciences Inc....
...N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Tufts University School of Medicine , Boston, Mass. Sidebars Hemera Biosciences Inc....
Items per page:
1 - 3 of 3
BioCentury | Jun 27, 2019
Product Development

Gene therapy’s next frontier lies beyond rare, monogenic diseases

...Whereas other companies’ programs target complement factors at more upstream points in the cascade, Hemera Biosciences Inc.’s...
...Harvard, Cambridge, Mass. Gyroscope Therapeutics Ltd., Stevenage, U.K. Encoded Therapeutics Inc., South San Francisco, Calif. Hemera Biosciences Inc....
...RTH258, esba1008) Eylea, VEGF Trap-Eye, aflibercept ophthalmic solution RGX-314 VY-AADC (VY-AADC01) AbbVie Inc. Adverum Biotechnologies Inc. Axovant Gene Therapies Ltd. Gyroscope Therapeutics Ltd. Hemera Biosciences Inc. Neurocrine...
BioCentury | Feb 22, 2019
Emerging Company Profile

Gyroscope complements dry AMD

...mAb tesidolumab. At least one other company is developing a gene therapy for dry AMD. Hemera Biosciences Inc....
...Companies and Institutions Mentioned Apellis Pharmaceuticals Inc. (NASDAQ:APLS), Crestwood, Ky. Gyroscope Therapeutics Ltd., Stevenage, U.K. Hemera Biosciences Inc....
BioCentury | Oct 21, 2013
Emerging Company Profile

Hemera: Special sauce in AMD

...and Institutions Mentioned Bayer AG (Xetra:BAYN), Leverkusen, Germany Genentech Inc. , South San Francisco, Calif. Hemera Biosciences Inc....
...N.Y. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Tufts University School of Medicine , Boston, Mass. Sidebars Hemera Biosciences Inc....
Items per page:
1 - 3 of 3